| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 3.71% | JP Morgan | $21 → $19 | Maintains | Underweight |
| 08/08/2023 | 3.71% | Credit Suisse | $18 → $19 | Maintains | Neutral |
| 05/08/2023 | 25.55% | Citigroup | $17 → $23 | Maintains | Neutral |
| 05/08/2023 | -1.75% | Credit Suisse | $17 → $18 | Maintains | Neutral |
| 05/08/2023 | 31% | UBS | $22 → $24 | Maintains | Buy |
| 05/08/2023 | 14.63% | Baird | $18 → $21 | Maintains | Neutral |
| 03/08/2023 | -7.21% | Citigroup | $20 → $17 | Maintains | Neutral |
| 03/07/2023 | -7.21% | Credit Suisse | $20 → $17 | Maintains | Neutral |
| 03/01/2023 | -1.75% | Baird | $23 → $18 | Maintains | Neutral |
| 11/03/2022 | 9.17% | Citigroup | $18 → $20 | Maintains | Neutral |
| 10/14/2022 | 9.17% | Credit Suisse | $37 → $20 | Maintains | Hold Neutral |
| 10/13/2022 | -1.75% | Citigroup | $52 → $18 | Downgrades | Buy → Neutral |
| 10/12/2022 | 20.09% | Baird | $62 → $22 | Downgrades | Outperform → Neutral |
| 08/04/2022 | 238.43% | Baird | $70 → $62 | Maintains | Outperform |
| 08/04/2022 | 101.97% | Credit Suisse | $43 → $37 | Maintains | Neutral |
| 02/28/2022 | 134.72% | Credit Suisse | $42 → $43 | Maintains | Neutral |
| 08/04/2021 | 129.26% | Credit Suisse | $43 → $42 | Maintains | Neutral |
| 05/27/2021 | 134.72% | Credit Suisse | $38 → $43 | Maintains | Neutral |
| 05/11/2021 | 107.42% | Credit Suisse | $34 → $38 | Maintains | Neutral |
| 11/05/2020 | 47.38% | UBS | $13 → $27 | Maintains | Neutral |
| 09/25/2020 | 20.09% | Credit Suisse | $18 → $22 | Maintains | Neutral |
| 09/25/2020 | 9.17% | Barclays | → $20 | Upgrades | Underweight → Equal-Weight |
| 08/07/2020 | -12.66% | Credit Suisse | $17 → $16 | Maintains | Neutral |
| 07/22/2020 | -45.41% | Barclays | $4 → $10 | Maintains | Underweight |
| 06/10/2020 | -48.14% | CFRA | $8.5 → $9.5 | Maintains | Buy |
| 05/07/2020 | -53.6% | CFRA | $11 → $8.5 | Maintains | Buy |
| 05/05/2020 | -56.33% | Baird | → $8 | Downgrades | Outperform → Neutral |
| 03/30/2020 | -50.87% | CFRA | $5.5 → $9 | Upgrades | Hold → Buy |
| 01/21/2020 | -50.87% | Baird | → $9 | Upgrades | Neutral → Outperform |
| 01/17/2019 | -56.33% | UBS | → $8 | Initiates Coverage On | → Neutral |
| 01/03/2019 | -61.79% | B of A Securities | $11 → $7 | Reiterates | Neutral → Neutral |
What is the target price for Owens & Minor (OMI)?
The latest price target for Owens & Minor (NYSE: OMI) was reported by JP Morgan on November 17, 2023. The analyst firm set a price target for $19.00 expecting OMI to rise to within 12 months (a possible 3.71% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Owens & Minor (OMI)?
The latest analyst rating for Owens & Minor (NYSE: OMI) was provided by JP Morgan, and Owens & Minor maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Owens & Minor (OMI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Owens & Minor, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Owens & Minor was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating Owens & Minor (OMI) correct?
While ratings are subjective and will change, the latest Owens & Minor (OMI) rating was a maintained with a price target of $21.00 to $19.00. The current price Owens & Minor (OMI) is trading at is $18.32, which is out of the analyst's predicted range.